PORTFOLIO｜UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.

Drug discovery based on gene network analysis 【Listed on TSE Growth Market : 2160】

Carring out R&D for pharmaceutical products that use micellar nanoparticle technology

Spin-off pharmaceutical R&D company that works on drug discovery 【Listed on TSE Growth Market】

Provides medical data and information to health insurance associations and pharmaceutical companies

Provide innovative peptide discovery platform system for drug discovery and development 【Listed on TSE Prime Market】

In-licensing and development, out-licensing of small molecule therapeutics. 【TYO: 4875】

Highly functional antibody drug discovery and development platform based on next generation sequencing and bioinformatics

Providing testing and drug discovery platform services using immune-diversity analysis

Providing material production services using long DNA synthesis and amplification technologies

Development of high-purity biopharmaceuticals with glycopeptide and glycoprotein manufactured by chemical synthesis

Life Science & Healthcare(Exited)